San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Alterome Therapeutics is raising $63,799,991.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Eric Murphy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Alterome Therapeutics
Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. The company will be led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs.

To learn more about Alterome Therapeutics, visit http://www.alterome.com

Contact:
Eric Murphy, Chief Executive Officer
650-493-9300
https://www.linkedin.com/in/murphness/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved